Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 11
Submit an article Journal homepage
40
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Dose-intensified CHOP (Double-CHOP) Followed by Consolidation with High-dose Chemotherapy for High and High-intermediate Risk Aggressive Non-Hodgkin's Lymphomas

Tetsuo Yamazaki First Department of Internal Medicine, Nihon University School of Medicine, 30-1 Oyaguchikami-cho, Itabashi-ku, Tokyo 173-8610, Japan
,
Umihiko Sawada First Department of Internal Medicine, Nihon University School of Medicine, 30-1 Oyaguchikami-cho, Itabashi-ku, Tokyo 173-8610, Japan
,
Yoshimasa Kura First Department of Internal Medicine, Nihon University School of Medicine, 30-1 Oyaguchikami-cho, Itabashi-ku, Tokyo 173-8610, Japan
,
Takeyoshi Ito First Department of Internal Medicine, Nihon University School of Medicine, 30-1 Oyaguchikami-cho, Itabashi-ku, Tokyo 173-8610, Japan
,
Yoshitaka Kaneita First Department of Internal Medicine, Nihon University School of Medicine, 30-1 Oyaguchikami-cho, Itabashi-ku, Tokyo 173-8610, Japan
,
Kiyotaka Yasukawa First Department of Internal Medicine, Nihon University School of Medicine, 30-1 Oyaguchikami-cho, Itabashi-ku, Tokyo 173-8610, Japan
&
Takashi Horie First Department of Internal Medicine, Nihon University School of Medicine, 30-1 Oyaguchikami-cho, Itabashi-ku, Tokyo 173-8610, Japan
 show all
Pages 2117-2123 | Published online: 01 Jul 2009

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Hiromichi Takahashi, Katsuhiro Miura, Masaru Nakagawa, Masahiko Sugitani, Yusuke Amano, Daisuke Kurita, Masashi Sakagami, Shimon Ohtake, Yoshihito Uchino, Hitomi Kodaira, Noriyoshi Iriyama, Sumiko Kobayashi, Atsuko Hojo, Yujin Kobayashi, Yukio Hirabayashi, Machiko Kusuda, Yoshihiro Hatta, Tomohiro Nakayama & Masami Takei. (2016) Negative impact of concurrent overexpression of MYC and BCL2 in patients with advanced diffuse large B-cell lymphoma treated with dose-intensified immunochemotherapy. Leukemia & Lymphoma 57:12, pages 2784-2790.
Read now

Articles from other publishers (5)

Marijke Linschoten, Janine A M Kamphuis, Anna van Rhenen, Laurens P Bosman, Maarten J Cramer, Pieter A Doevendans, Arco J Teske & Folkert W Asselbergs. (2020) Cardiovascular adverse events in patients with non-Hodgkin lymphoma treated with first-line cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R-CHOP): a systematic review and meta-analysis. The Lancet Haematology 7:4, pages e295-e308.
Crossref
Daisuke Kurita, Katsuhiro Miura, Masaru Nakagawa, Shimon Ohtake, Masashi Sakagami, Yoshihito Uchino, Hiromichi Takahashi, Satomi Kiso, Atsuko Hojo, Hitomi Kodaira, Mai Yagi, Yukio Hirabayashi, Yujin Kobayashi, Noriyoshi Iriyama, Sumiko Kobayashi, Yoshihiro Hatta, Yoshimasa Kura, Masahiko Sugitani & Masami Takei. (2015) Dose-intensified CHOP with rituximab (R-Double-CHOP) followed by consolidation high-dose chemotherapies for patients with advanced diffuse large B-cell lymphoma. International Journal of Hematology 101:6, pages 585-593.
Crossref
NORIYOSHI IRIYAMA, HIROMICHI TAKAHASHI, YOSHIHIRO HATTA, KATSUHIRO MIURA, YUJIN KOBAYASHI, DAISUKE KURITA, YUKIO HIRABAYASHI, ATSUKO HOJO, HITOMI KODAIRA, MAI YAGI, SATOMI KISO, YOSHIHITO UCHINO, MASARU NAKAGAWA, MACHIKO KUSUDA, SUMIKO KOBAYASHI, AKIRA HORIKOSHI, YOSHIMASA KURA, TETSUO YAMAZAKI, UMIHIKO SAWADA & JIN TAKEUCHI. (2013) Efficacy of a dose-intensified CHOP (Double-CHOP) regimen for peripheral T-cell lymphomas. Oncology Reports 29:2, pages 805-811.
Crossref
Yujin Kobayashi, Yoshihiro Hatta, Yukio Hirabayashi, Atsuko Hojo, Toshitake Tanaka, Kazuhiro Takei, Hikari Ishizuka, Masahiko Sugitani, Shin Aizawa & Jin Takeuchi. (2011) Positive Expression of Macrophage Inflammatory Protein-1.ALPHA. and-1.BETA. in a Patient with Diffuse Large B-cell Lymphoma Accompanied by Hypercalcemia and Multiple Osteolysis. Journal of Nihon University Medical Association 70:2, pages 112-115.
Crossref
. (2003) Current Awareness in Hematological Oncology. Hematological Oncology 21:1, pages 43-50.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.